Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


Articles published in Int J Hematol

Retrieve available abstracts of 109 articles:
HTML format
Text format



Single Articles


    August 2017
  1. HARA R, Onizuka M, Matsusita E, Kikkawa E, et al
    NKG2D gene polymorphisms are associated with disease control of chronic myeloid leukemia by dasatinib.
    Int J Hematol. 2017 Aug 9. doi: 10.1007/s12185-017-2294.
    PubMed     Text format     Abstract available


  2. MIYAWAKI S
    JSH guideline for tumors of hematopoietic and lymphoid tissues: leukemia 1. Acute myeloid leukemia (AML).
    Int J Hematol. 2017 Aug 7. doi: 10.1007/s12185-017-2303.
    PubMed     Text format    


    July 2017
  3. GEYER JT, Mathew S
    Myelomonocytic leukemia with intracytoplasmic crystalline inclusions, double minute chromosomes and MYC amplification.
    Int J Hematol. 2017 Jul 28. doi: 10.1007/s12185-017-2299.
    PubMed     Text format    


  4. DI IANNI M, Olioso P, Giancola R, Santarone S, et al
    Treg-protected donor lymphocyte infusions: a new tool to address the graft-versus-leukemia effect in the absence of graft-versus-host disease in patients relapsed after HSCT.
    Int J Hematol. 2017 Jul 18. doi: 10.1007/s12185-017-2292.
    PubMed     Text format     Abstract available


  5. REA D, Cayuela JM
    Treatment-free remission in patients with chronic myeloid leukemia.
    Int J Hematol. 2017 Jul 8. doi: 10.1007/s12185-017-2295.
    PubMed     Text format     Abstract available


  6. HIRANO M, Ohno N, Tanosaki R, Mochizuki M, et al
    Adult T-cell leukemia cell-induced uveitis: rapid increase in adult T-cell leukemia cells disrupts the blood-ocular barrier.
    Int J Hematol. 2017 Jul 4. doi: 10.1007/s12185-017-2293.
    PubMed     Text format     Abstract available


  7. MIYAZAKI Y
    JSH Guideline for Tumors of Hematopoietic and Lymphoid Tissues: Leukemia: 6. Myelodysplastic syndromes (MDS).
    Int J Hematol. 2017 Jul 4. doi: 10.1007/s12185-017-2272.
    PubMed     Text format    


  8. UEMURA S, Tamura A, Saito A, Hasegawa D, et al
    Reemergence of translocation t(11;19)(q23;p13.1) in the absence of clinically overt leukemia.
    Int J Hematol. 2017 Jul 1. doi: 10.1007/s12185-017-2289.
    PubMed     Text format     Abstract available


  9. KUNIMOTO H, Nakajima H
    Epigenetic dysregulation of hematopoietic stem cells and preleukemic state.
    Int J Hematol. 2017;106:34-44.
    PubMed     Text format     Abstract available


  10. KARIGANE D, Takubo K
    Metabolic regulation of hematopoietic and leukemic stem/progenitor cells under homeostatic and stress conditions.
    Int J Hematol. 2017;106:18-26.
    PubMed     Text format     Abstract available


  11. MATSUO H, Shiga S, Imai T, Kamikubo Y, et al
    Purification of leukemic blast cells from blood smears using laser microdissection.
    Int J Hematol. 2017;106:55-59.
    PubMed     Text format     Abstract available


    June 2017
  12. TANG S, Shen H, Mao X, Dai H, et al
    FLT3-ITD with DNMT3A R882 double mutation is a poor prognostic factor in Chinese patients with acute myeloid leukemia after chemotherapy or allogeneic hematopoietic stem cell transplantation.
    Int J Hematol. 2017 Jun 14. doi: 10.1007/s12185-017-2256.
    PubMed     Text format     Abstract available


  13. ISHITSUKA K, Yurimoto S, Kawamura K, Tsuji Y, et al
    Safety and efficacy of mogamulizumab in patients with adult T-cell leukemia-lymphoma in Japan: interim results of postmarketing all-case surveillance.
    Int J Hematol. 2017 Jun 9. doi: 10.1007/s12185-017-2270.
    PubMed     Text format     Abstract available


  14. ZHANG R, Chen J, Huang H, Ma J, et al
    Erratum to: Primary fungal prophylaxis in acute leukemia patients with different risk factors: retrospective analysis from the CAESAR study.
    Int J Hematol. 2017 Jun 2. doi: 10.1007/s12185-017-2269.
    PubMed     Text format    


  15. ITZYKSON R, Duchmann M, Lucas N, Solary E, et al
    CMML: Clinical and molecular aspects.
    Int J Hematol. 2017;105:711-719.
    PubMed     Text format     Abstract available


    May 2017
  16. TAMURA A, Uemura S, Saito A, Okubo S, et al
    Congenital immature pure erythroid leukemia with E-cadherin expression.
    Int J Hematol. 2017 May 18. doi: 10.1007/s12185-017-2248.
    PubMed     Text format     Abstract available


  17. MINAKATA D, Fujiwara SI, Ikeda T, Toda Y, et al
    Relationship between white blood cell count elevation and clinical response after G-CSF priming chemotherapy for acute myeloid leukemia.
    Int J Hematol. 2017 May 15. doi: 10.1007/s12185-017-2251.
    PubMed     Text format     Abstract available


  18. HANEKAMP D, Cloos J, Schuurhuis GJ
    Leukemic stem cells: identification and clinical application.
    Int J Hematol. 2017;105:549-557.
    PubMed     Text format     Abstract available


  19. TAKAGI M, Ishiwata Y, Aoki Y, Miyamoto S, et al
    HLA haploidentical hematopoietic cell transplantation using clofarabine and busulfan for refractory pediatric hematological malignancy.
    Int J Hematol. 2017;105:686-691.
    PubMed     Text format     Abstract available


  20. CAMACHO V, McClearn V, Patel S, Welner RS, et al
    Regulation of normal and leukemic stem cells through cytokine signaling and the microenvironment.
    Int J Hematol. 2017;105:566-577.
    PubMed     Text format     Abstract available


  21. IKEGAME K, Kaida K, Yoshihara S, Yoshihara K, et al
    Spousal hematopoietic stem cell transplantation.
    Int J Hematol. 2017;105:646-657.
    PubMed     Text format     Abstract available


  22. URESHINO H, Kizuka H, Kusaba K, Sano H, et al
    5q- syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10).
    Int J Hematol. 2017;105:692-696.
    PubMed     Text format     Abstract available


    April 2017
  23. TOJO A, Kyo T, Yamamoto K, Nakamae H, et al
    Ponatinib in Japanese patients with Philadelphia chromosome-positive leukemia, a phase 1/2 study.
    Int J Hematol. 2017 Apr 25. doi: 10.1007/s12185-017-2238.
    PubMed     Text format     Abstract available


  24. HATAKE K, Ogura M, Takada K, Taniwaki M, et al
    Ofatumumab combined with chlorambucil for previously untreated chronic lymphocytic leukemia: a phase I/II, open-label study in Japan.
    Int J Hematol. 2017 Apr 18. doi: 10.1007/s12185-017-2233.
    PubMed     Text format     Abstract available


  25. KE S, Li RC, Lu J, Meng FK, et al
    MicroRNA-192 regulates cell proliferation and cell cycle transition in acute myeloid leukemia via interaction with CCNT2.
    Int J Hematol. 2017 Apr 13. doi: 10.1007/s12185-017-2232.
    PubMed     Text format     Abstract available


  26. TAKAHASHI N, Nakaseko C, Kobayashi Y, Miyamura K, et al
    Long-term treatment with bosutinib in a phase 1/2 study in Japanese chronic myeloid leukemia patients resistant/intolerant to prior tyrosine kinase inhibitor treatment.
    Int J Hematol. 2017 Apr 13. doi: 10.1007/s12185-017-2239.
    PubMed     Text format     Abstract available


  27. IGUCHI A, Cho Y, Sugiyama M, Terashita Y, et al
    Bortezomib combined with standard induction chemotherapy in Japanese children with refractory acute lymphoblastic leukemia.
    Int J Hematol. 2017 Apr 11. doi: 10.1007/s12185-017-2235.
    PubMed     Text format     Abstract available


  28. ONG SY, Ho LP, Yeo PM, Ng HJ, et al
    Marked hypereosinophilia and rash as initial presentation of acute myeloid leukemia with t(8;21).
    Int J Hematol. 2017 Apr 7. doi: 10.1007/s12185-017-2230.
    PubMed     Text format    


  29. ZHANG R, Chen J, Huang H, Ma J, et al
    Primary fungal prophylaxis in acute leukemia patients with different risk factors: retrospective analysis from the CAESAR study.
    Int J Hematol. 2017 Apr 7. doi: 10.1007/s12185-017-2224.
    PubMed     Text format     Abstract available


  30. SUH KJ, Lee JY, Shin DY, Koh Y, et al
    Analysis of adverse events associated with dasatinib and nilotinib treatments in chronic-phase chronic myeloid leukemia patients outside clinical trials.
    Int J Hematol. 2017 Apr 4. doi: 10.1007/s12185-017-2225.
    PubMed     Text format     Abstract available


  31. YAGUCHI A, Ishibashi T, Terada K, Ueno-Yokohata H, et al
    EP300-ZNF384 fusion gene product up-regulates GATA3 gene expression and induces hematopoietic stem cell gene expression signature in B-cell precursor acute lymphoblastic leukemia cells.
    Int J Hematol. 2017 Apr 4. doi: 10.1007/s12185-017-2220.
    PubMed     Text format     Abstract available


  32. ASANO M, Umezu T, Katagiri S, Kobayashi C, et al
    Up-regulated exosomal miRNA-140-3p in CML patients with musculoskeletal pain associated with discontinuation of tyrosine kinase inhibitors.
    Int J Hematol. 2017;105:419-422.
    PubMed     Text format     Abstract available


    March 2017
  33. NAKAMAE H, Fujisawa S, Ogura M, Uchida T, et al
    Dasatinib versus imatinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia: a subanalysis of the DASISION 5-year final report.
    Int J Hematol. 2017 Mar 24. doi: 10.1007/s12185-017-2208.
    PubMed     Text format     Abstract available


  34. BARAKA A, Sherief LM, Kamal NM, Shorbagy SE, et al
    Detection of minimal residual disease in childhood B-acute lymphoblastic leukemia by 4-color flowcytometry.
    Int J Hematol. 2017 Mar 21. doi: 10.1007/s12185-017-2206.
    PubMed     Text format     Abstract available


  35. KATZ BZ, Herishanu Y
    Fragility of sub-cellular structures in chronic lymphocytic leukemia.
    Int J Hematol. 2017 Mar 21. doi: 10.1007/s12185-017-2218.
    PubMed     Text format    


  36. ISHIHARA T, Nogami K, Matsumoto T, Nomura A, et al
    Potentially life-threatening coagulopathy associated with simultaneous reduction in coagulation and fibrinolytic function in pediatric acute leukemia after hematopoietic stem-cell transplantation.
    Int J Hematol. 2017 Mar 16. doi: 10.1007/s12185-017-2213.
    PubMed     Text format     Abstract available


  37. HASSAN IB, Zaabi MR, Alam A, Hashim MJ, et al
    Characteristics features and factors influencing early death in Acute promyelocytic leukemia; Experience from United Arab Emirates (UAE).
    Int J Hematol. 2017 Mar 14. doi: 10.1007/s12185-017-2211.
    PubMed     Text format     Abstract available


  38. LOVATO S, Ayto R
    Haemolysis in female patient with chronic phase CML.
    Int J Hematol. 2017;105:233-234.
    PubMed     Text format    


  39. KANAMITSU K, Shimada A, Nishiuchi R, Shigemura T, et al
    Pediatric intestinal Behcet disease complicated by myeloid malignancies.
    Int J Hematol. 2017;105:377-382.
    PubMed     Text format     Abstract available


    February 2017
  40. MOLTENI A, Riva M, Ravano E, Marbello L, et al
    Clofarabine-based chemotherapy as a bridge to transplant in the setting of refractory or relapsed acute myeloid leukemia, after at least one previous unsuccessful salvage treatment containing fludarabine: a single institution experience.
    Int J Hematol. 2017 Feb 20. doi: 10.1007/s12185-017-2198.
    PubMed     Text format     Abstract available


  41. SHIGEMATSU A, Kako S, Mitsuhashi K, Iwato K, et al
    Allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia who had central nervous system involvement: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation.
    Int J Hematol. 2017 Feb 14. doi: 10.1007/s12185-017-2197.
    PubMed     Text format     Abstract available


  42. IWASA M, Miura Y, Fujishiro A, Fujii S, et al
    Erratum to: Bortezomib interferes with adhesion of B cell precursor acute lymphoblastic leukemia cells through SPARC up-regulation in human bone marrow mesenchymal stromal/stem cells.
    Int J Hematol. 2017 Feb 9. doi: 10.1007/s12185-017-2182.
    PubMed     Text format    


  43. YOKOYAMA H, Takahashi N, Katsuoka Y, Inomata M, et al
    Evaluation of the safety and efficacy of recombinant soluble thrombomodulin for patients with disseminated intravascular coagulation associated with acute leukemia: multicenter prospective study by the Tohoku Hematology Forum.
    Int J Hematol. 2017 Feb 7. doi: 10.1007/s12185-017-2190.
    PubMed     Text format     Abstract available


  44. OGAWA Y, Izutsu K, Kiguchi T, Choi I, et al
    A multicenter, single-arm, Phase II clinical trial of bendamustine monotherapy in patients with chronic lymphocytic leukemia in Japan.
    Int J Hematol. 2017 Feb 3. doi: 10.1007/s12185-016-2178.
    PubMed     Text format     Abstract available


    January 2017
  45. REYNA-FIGUEROA J, Lagunas-Martinez A, Galindo-Delgado P, Fernandez-Bautista MF, et al
    Serum concentrations of apoptosis-associated molecules in septic children with leukemia, neutropenia and fever.
    Int J Hematol. 2017 Jan 31. doi: 10.1007/s12185-016-2175.
    PubMed     Text format     Abstract available


  46. OKSENHENDLER E, Turpin J, Lhote R, Cassar O, et al
    Persistent risk of adult T-cell leukemia/lymphoma after neonatal HTLV-1 infection through exchange transfusion.
    Int J Hematol. 2017 Jan 30. doi: 10.1007/s12185-016-2174.
    PubMed     Text format     Abstract available


  47. ANDO T, Yamazaki E, Ogusa E, Ishii Y, et al
    Body mass index is a prognostic factor in adult patients with acute myeloid leukemia.
    Int J Hematol. 2017 Jan 21. doi: 10.1007/s12185-017-2183.
    PubMed     Text format     Abstract available


  48. IWASA M, Miura Y, Fujishiro A, Fujii S, et al
    Bortezomib interferes with adhesion of B cell precursor acute lymphoblastic leukemia cells through SPARC up-regulation in human bone marrow mesenchymal stromal/stem cells.
    Int J Hematol. 2017 Jan 2. doi: 10.1007/s12185-016-2169.
    PubMed     Text format     Abstract available


  49. WAISBREN J, Dinner S, Altman J, Frankfurt O, et al
    Disease characteristics and prognosis of myelodysplastic syndrome presenting with isolated thrombocytopenia.
    Int J Hematol. 2017;105:44-51.
    PubMed     Text format     Abstract available


    December 2016
  50. SHIMOMURA Y, Maruoka H, Ishikawa T
    Marked response to imatinib mesylate in a patient with platelet-derived growth factor receptor beta-associated acute myeloid leukemia.
    Int J Hematol. 2016 Dec 20. doi: 10.1007/s12185-016-2167.
    PubMed     Text format     Abstract available


  51. ISMAIL MM, Abdulateef NA
    Bone marrow T-cell percentage: A novel prognostic indicator in acute myeloid leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


    November 2016
  52. MORITA M, Nishinaka Y, Kato I, Saida S, et al
    Dasatinib induces autophagy in mice with Bcr-Abl-positive leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  53. HAJI S, Shiratsuchi M, Matsushima T, Takamatsu A, et al
    Achievement of disease control with donor-derived EB virus-specific cytotoxic T cells after allogeneic peripheral blood stem cell transplantation for aggressive NK-cell leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  54. UEMURA M, Imataki O, Kawachi Y, Kawakami K, et al
    Charlson comorbidity index predicts poor outcome in CML patients treated with tyrosine kinase inhibitor.
    Int J Hematol. 2016;104:621-627.
    PubMed     Text format     Abstract available


  55. JUNG KS, Cho SH, Kim SJ, Ko YH, et al
    Clinical features and treatment outcome of Epstein-Barr virus-positive nodal T-cell lymphoma.
    Int J Hematol. 2016;104:591-595.
    PubMed     Text format     Abstract available


  56. RUBIO P, Campos B, Digiorge JA, Gallego MS, et al
    NPM1, FLT3 and CEBPA mutations in pediatric patients with AML from Argentina: incidence and prognostic value.
    Int J Hematol. 2016;104:582-590.
    PubMed     Text format     Abstract available


  57. MONIKA BELICKOVA M, Merkerova MD, Votavova H, Valka J, et al
    Up-regulation of ribosomal genes is associated with a poor response to azacitidine in myelodysplasia and related neoplasms.
    Int J Hematol. 2016;104:566-573.
    PubMed     Text format     Abstract available


    October 2016
  58. YANG W, Ernst P
    SET/MLL family proteins in hematopoiesis and leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  59. MAZUMDAR C, Majeti R
    The role of mutations in the cohesin complex in acute myeloid leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  60. SUKNUNTHA K, Thita T, Togarrati PP, Ratanachamnong P, et al
    Wnt signaling inhibitor FH535 selectively inhibits cell proliferation and potentiates imatinib-induced apoptosis in myeloid leukemia cell lines.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  61. BADAT M, Oyesanya F, Cervi P
    CLL with intra-cytoplasmic lymphocytic inclusion bodies.
    Int J Hematol. 2016;104:411-2.
    PubMed     Text format    


    September 2016
  62. KAWAMOTO S, Yamamoto K, Toyoda M, Yakushijin K, et al
    Constitutional t(8;22)(q24;q11.2) that mimics the variant Burkitt-type translocation in Philadelphia chromosome-positive chronic myeloid leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  63. TANAHASHI T, Sekiguchi N, Matsuda K, Matsumoto A, et al
    A screening method with lymphocyte percentage and proportion of granular lymphocytes in the peripheral blood for large granular lymphocyte (LGL) leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


    August 2016
  64. TSUBOKURA Y, Satake A, Hotta M, Yoshimura H, et al
    Successful treatment with mogamulizumab followed by allogeneic hematopoietic stem-cell transplantation in adult T-cell leukemia/lymphoma: a report of two cases.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  65. SAKAMOTO K, Tanaka S, Tomoyasu C, Tomii T, et al
    Development of acute lymphoblastic leukemia with IgH-EPOR in a patient with secondary erythrocytosis.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  66. OGIYA D, Matsushita H, Murayama H, Ando K, et al
    Chediak-Higashi-like granules and waxy Auer bodies in a case of acute promyelocytic leukemia.
    Int J Hematol. 2016.
    PubMed     Text format    


  67. YAMAMOTO K, Minami Y, Kawamoto S, Yakushijin K, et al
    Sea-blue histiocytes in acute myeloid leukemia with trisomy 9.
    Int J Hematol. 2016.
    PubMed     Text format    


  68. LAM YM, Chan YF, Chan LC, Ng RK, et al
    Histone deacetylase inhibitors induce leukemia gene expression in cord blood hematopoietic stem cells expanded ex vivo.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


    July 2016
  69. HINO A, Yoshida H, Tada Y, Koike M, et al
    Changes from imatinib mesylate to second generation tyrosine kinase inhibitors improve renal impairment with imatinib mesylate in chronic myelogenous leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  70. ICHIKAWA K, Edahiro Y, Gotoh A, Iiduka K, et al
    Co-occurrence of hyperleukocytosis and elevated fibrin-fibrinogen degradation product levels is a risk factor for early intracranial hemorrhage in patients with de novo acute leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  71. KWON JH, Koh YI, Yoon SS, Park S, et al
    Clinical outcome and efficacy of current anti-leukemic therapy for leptomeningeal involvement in acute myeloid leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  72. KUTLAY NY, Pekpak E, Altiner S, Ileri T, et al
    Prognostic impact of RUNX1 and ETV6 gene copy number on pediatric B-cell precursor acute lymphoblastic leukemia with or without hyperdiploidy.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  73. AOKI S, Firouzi S, Lopez Y, Yamochi T, et al
    Transition of adult T-cell leukemia/lymphoma clones during clinical progression.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  74. DAVILA ML, Sadelain M
    Biology and clinical application of CAR T cells for B cell malignancies.
    Int J Hematol. 2016;104:6-17.
    PubMed     Text format     Abstract available


    June 2016
  75. NISHI Y, Fukushima T, Nomura S, Tomoyose T, et al
    Characterization of patients with aggressive adult T-cell leukemia-lymphoma in Okinawa, Japan: a retrospective analysis of a large cohort.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  76. ZHANG X, Tu H, Yang Y, Wan Q, et al
    High IL-7 levels in the bone marrow microenvironment mediate imatinib resistance and predict disease progression in chronic myeloid leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  77. KURIYAMA T, Kawano N, Yamashita K, Kikuchi I, et al
    Two cases of primary adult T-cell leukemia/lymphoma of bone: case reports and a review of the literature.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  78. OSHIMA Y, Yuji K, Tojo A
    "Imatinib-induced gastric antral vascular ectasia" in a reporting system of the Japanese Adverse Drug Event Report database.
    Int J Hematol. 2016;103:596-8.
    PubMed     Text format    


  79. GARG S, Ghosh K, Madkaikar M
    Antigen expression on a putative leukemic stem cell population and AML blast.
    Int J Hematol. 2016;103:567-71.
    PubMed     Text format     Abstract available


  80. WANG X, Chu Y, Wang W, Yuan W, et al
    mTORC signaling in hematopoiesis.
    Int J Hematol. 2016;103:510-8.
    PubMed     Text format     Abstract available


    April 2016
  81. KOH K, Ogawa C, Okamoto Y, Kudo K, et al
    Phase 1 study of clofarabine in pediatric patients with relapsed/refractory acute lymphoblastic leukemia in Japan.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  82. AMMATUNA E
    Stepwise discriminant function analysis for rapid identification of acute promyelocytic leukemia: should this be the first choice to establish the diagnosis of APL?
    Int J Hematol. 2016.
    PubMed     Text format    


  83. HARADA M, Gale RP
    Commentary: How do haematopoietic cell transplants cure leukaemia?
    Int J Hematol. 2016;103:396-8.
    PubMed     Text format    


  84. MANABE A
    Guest Editorial: Inherited bone marrow failure and myelodysplasia in children: how much do we know about pediatric diseases?
    Int J Hematol. 2016;103:359.
    PubMed     Text format    


  85. SCHALK E, Heidel FH
    Leukemic mastopathy.
    Int J Hematol. 2016;103:357-8.
    PubMed     Text format    


    March 2016
  86. SARASHINA T, Iwabuchi H, Miyagawa N, Sekimizu M, et al
    Hematopoietic stem cell transplantation for pediatric mature B-cell acute lymphoblastic leukemia with non-L3 morphology and MLL-AF9 gene fusion: three case reports and review of the literature.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  87. LIU L, Yuan X
    Transient ischemic attack as an unusual initial manifestation of acute promyelocytic leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  88. ZHU H, Xu W, Liu H, Wang H, et al
    Expression of activated molecules on CD5B lymphocytes in autoimmune hemolytic anemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  89. SHIGEMURA T, Nishina S, Nakazawa H, Matsuda K, et al
    Early detection of Rhizopus DNA in the serum of a patient with rhino-orbital-cerebral mucormycosis following allogeneic hematopoietic stem cell transplantation.
    Int J Hematol. 2016;103:354-5.
    PubMed     Text format    


    February 2016
  90. SAIDA S
    Evolution of myeloid leukemia in children with Down syndrome.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  91. JIANG Y, Nakada D
    Cell intrinsic and extrinsic regulation of leukemia cell metabolism.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  92. GOTO S, Goto H, Yokosuka T
    The combination effects of bendamustine with antimetabolites against childhood acute lymphoblastic leukemia cells.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  93. KATAGIRI S, Gotoh M, Tone K, Akahane D, et al
    Fatal Cyberlindnera fabianii fungemia in a patient with mixed phenotype acute leukemia after umbilical cord blood transplantation.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  94. OTSUKA Y, Kondo T, Nakamoto Y, Haga H, et al
    18F-FDG PET/CT and MRI findings in a case of granulocytic sarcoma of the breast.
    Int J Hematol. 2016;103:117-8.
    PubMed     Text format    


  95. MITSUI T, Koiso H, Nakahashi H, Saitoh A, et al
    SF3B1 and IGHV gene mutation status predict poor prognosis in Japanese CLL patients.
    Int J Hematol. 2016;103:219-26.
    PubMed     Text format     Abstract available


  96. CHAVDA S, Liapis K
    Detection of mycobacteria in MGG-stained bone marrow smears.
    Int J Hematol. 2016;103:115-6.
    PubMed     Text format    


    January 2016
  97. SUBARI S, Baidoun F, Hreh M, Patnaik M, et al
    Prior hypomethylating agent use lacks impact on clinical outcome in patients with secondary acute myeloid leukemia arising from myelodysplastic syndromes treated with standard induction chemotherapy.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  98. YANADA M, Yamamoto Y, Iba S, Okamoto A, et al
    TP53 mutations in older adults with acute myeloid leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  99. KEINO D, Kinoshita A, Tomizawa D, Takahashi H, et al
    Residual disease detected by multidimensional flow cytometry shows prognostic significance in childhood acute myeloid leukemia with intermediate cytogenetics and negative FLT3-ITD: a report from the Tokyo Children's Cancer Study Group.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  100. CHEN Z, Li Y, Tong Y, Gao Q, et al
    Stepwise discriminant function analysis for rapid identification of acute promyelocytic leukemia from acute myeloid leukemia with multiparameter flow cytometry.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  101. HIRADE T, Abe M, Onishi C, Taketani T, et al
    Internal tandem duplication of FLT3 deregulates proliferation and differentiation and confers resistance to the FLT3 inhibitor AC220 by Up-regulating RUNX1 expression in hematopoietic cells.
    Int J Hematol. 2016;103:95-106.
    PubMed     Text format     Abstract available


    December 2015
  102. NAKAMURA Y, Tokita K, Nagasawa F, Takahashi W, et al
    Chronic myelogenous leukemia in chronic phase transforming into acute leukemia under treatment with dasatinib 4 months after diagnosis.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


    November 2015
  103. MOHREN M, Jentsch-Ullrich K, Koenigsmann M, Kropf S, et al
    High coagulation factor VIII and von Willebrand factor in patients with lymphoma and leukemia.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


  104. OKAMOTO Y, Koga Y, Inagaki J, Ozono S, et al
    Effective VCR/DEX pulse maintenance therapy in the KYCCSG ALL-02 protocol for pediatric acute lymphoblastic leukemia.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


  105. YANAGISAWA R, Nakazawa Y, Sakashita K, Saito S, et al
    Intrathecal donor lymphocyte infusion for isolated leukemia relapse in the central nervous system following allogeneic stem cell transplantation: a case report and literature review.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


    August 2015
  106. NOMOTO H, Takami A, Espinoza JL, Matsuo K, et al
    A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


    July 2015
  107. MICHELIS FV, Bril V, Lipton JH
    A case report and literature review of chronic graft-versus-host disease manifesting as polymyositis.
    Int J Hematol. 2015;102:144-6.
    PubMed     Text format     Abstract available


  108. HOUWING ME, Koopman-Coenen EA, Kersseboom R, Gooskens S, et al
    Somatic thrombopoietin (THPO) gene mutations in childhood myeloid leukemias.
    Int J Hematol. 2015;102:140-3.
    PubMed     Text format     Abstract available


    June 2015
  109. SREEDHARANUNNI S, Varma N, Sachdeva MU, Gupta K, et al
    CD103+ gammadelta T cell large granular lymphocytosis in a patient with refractory celiac disease: a diagnostic enigma.
    Int J Hematol. 2015;101:603-7.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: